Full-Time

Quality Engineer 2-3

Quality Assurance

MedPharm

MedPharm

Topical and transdermal drug delivery CDMO

No salary listed

Durham, NC, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
Word/Pages/Docs
Quality Assurance (QA)
Excel/Numbers/Sheets
Microsoft Outlook
Requirements
  • At least 5 years of Quality Assurance experience in the pharmaceutical industry.
  • Knowledge of pharmaceutical Quality Management System requirements and execution.
  • Proficiency in written, verbal, and face-to-face communication for presenting information to internal and external customers.
  • Ability to manage multiple tasks and multifunctional resources concurrently while maintaining attention to detail and responding to changing priorities and deadlines.
  • Ability to identify problem root causes, propose potential solutions, and collaborate with others to resolve problems.
  • Ability to work independently and as part of a team.
  • Expertise in Microsoft Office, including Excel, Word, Outlook, and Project, and Adobe Pro.
  • Ability to meet the role's physical demands, including frequent standing and walking; carrying, bending, twisting, reaching, and gripping; and frequent lifting, pushing, and pulling of 20–60 pounds.
Responsibilities
  • Design, implement, and maintain the Quality Management System across the manufacturing lifecycle.
  • Support process validation and root-cause investigations for deviations.
  • Oversee Corrective and Preventive Actions and quality processes for incoming, in-process, and final disposition activities.
  • Review and release batch records for GMP, clinical, and commercial programs.
  • Release raw materials in coordination with other functional areas and agreed timelines.
  • Provide Quality Assurance oversight of operational metrics and support client and internal auditing activities.
  • Ensure production practices comply with FDA 21 CFR Parts 210/211, ICH Q10, and global current Good Manufacturing Practice standards.
  • Review and approve validation protocols for manufacturing equipment, facilities, utilities, and analytical laboratory software.
  • Investigate manufacturing deviations and out-of-specification results using root-cause analysis tools such as 5 Whys and Fishbone diagrams.
  • Review and approve manufacturing documentation, including specifications, batch records, and batch release documentation.
  • Support Quality Risk Management initiatives using Failure Mode and Effects Analysis to minimize patient and product risk.
  • Evaluate and approve change controls for processes, materials, and equipment.
  • Conduct internal audits and manage readiness documentation for external regulatory agency inspections.
  • Partner with procurement to audit third-party raw material suppliers and manage external quality issues.
  • Oversee quality management processes to ensure client, specification, and regulatory requirements are met by the Operations Unit.
  • Collaborate with production, engineering, supply chain, and customer service teams to address quality issues and drive continuous improvement.
  • Analyze quality data and performance metrics to identify trends, defect root causes, and process optimization opportunities.
  • Support Operations in closing Quality Events and quality improvement plans.
  • Draft and revise standard operating procedures and review master batch records.
  • Lead internal audits and support external audits; develop reports of audit findings and communicate them to relevant project teams and company management.
  • Perform other responsibilities or tasks within the employee's skills and abilities when reasonably requested.
Desired Qualifications
  • A Bachelor of Arts or Bachelor of Science degree in an engineering discipline, or equivalent experience.

MedPharm is a contract development and manufacturing organization specializing in topical, transdermal, and mucosal drug delivery. It provides end-to-end services from formulation development through clinical and commercial manufacturing, including analytical testing and regulatory support, and operates proprietary delivery platforms such as MedSpray, MedTherm, and AquaRMed. Its capabilities cover dermal, pulmonary, nasal, ophthalmic, and other mucosal routes, combining research services with a patent portfolio to support product lifecycle needs. In 2024 it merged with Tergus Pharma to expand into hormone-based and highly potent drugs, with the goal of helping pharmaceutical and biotech customers move from early formulation to scalable, reliable manufacturing for clinical and commercial use.

Company Size

N/A

Company Stage

Grant

Total Funding

$390K

Headquarters

Guildford, United Kingdom

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2025 CEO Bill Humphries signals post-merger growth execution and commercial discipline.
  • The Durham $4 million expansion created space for over 100 skilled hires in RTP.
  • Palvella's positive March 2026 Phase 3 readout and Purna partnership strengthen sponsor validation.

What critics are saying

  • MedPharm depends on niche topical spending; a sponsor slowdown hits utilization fast in 2025-2026.
  • The 2024 merger left some Tergus leaders exiting, creating integration and execution risk.
  • Topical CDMO giants and captive pharma plants can compress margins and steal repeat programs.

What makes MedPharm unique

  • MedPharm remains the topical and transepithelial CDMO specialist after the 2024 Tergus merger.
  • Durham and Guildford sites give MedPharm integrated development, clinical manufacturing, and commercial production.
  • August 2026 Olink CSP status adds proprietary proteomics beyond formulation and in vitro testing.

Help us improve and share your feedback! Did you find this helpful?

Company News

FinSMEs
Jul 9th, 2024
MedPharm and Tergus Pharma Merge

MedPharm, a Guildford, UK-based topical and transdermal Contract Development and Manufacturing Organization (CDMO) and Ampersand Capital Partners portfolio company, announced a merger with Tergus Pharma, a Research Triangle Park, NC-based end-to-end contract service provider and a Great Point Partners portfolio company

FinSMEs
Jul 8th, 2024
MedPharm and Tergus Pharma Merge

MedPharm, a UK-based CDMO, has merged with Tergus Pharma, a US-based contract service provider. The combined entity will operate under the MedPharm name, offering end-to-end drug development and manufacturing services. Michael Kane, Tergus Pharma CEO, will become CEO of MedPharm, while Patrick Walsh remains Executive Chairman. Great Point Partners retains a significant minority stake, with Ampersand Capital Partners and Bourne Partners Strategic Capital holding majority ownership.